Tavernier, S.J.* ; Athanasopoulos, V.* ; Verloo, P.* ; Behrens, G. ; Staal, J.* ; Bogaert, D.J.* ; Naesens, L.* ; De Bruyne, M.* ; Van Gassen, S.* ; Parthoens, E.* ; Ellyard, J.* ; Cappello, J.* ; Morris, L.X.* ; Van Gorp, H.* ; Van Isterdael, G.* ; Saeys, Y.* ; Lamkanfi, M.* ; Schelstraete, P.* ; Dehoorne, J.* ; Bordon, V.* ; van Coster, R.* ; Lambrecht, B.N.* ; Menten, B.* ; Beyaert, R.* ; Vinuesa, C.G.* ; Heissmeyer, V. ; Dullaers, M.* ; Haerynck, F.*
A human immune dysregulation syndrome characterized by severe hyperinflammation with a homozygous nonsense Roquin-1 mutation.
Nat. Commun. 10:4779 (2019)
Hyperinflammatory syndromes are life-threatening disorders caused by overzealous immune cell activation and cytokine release, often resulting from defects in negative feedback mechanisms. In the quintessential hyperinflammatory syndrome familial hemophagocytic lymphohistiocytosis (HLH), inborn errors of cytotoxicity result in effector cell accumulation, immune dysregulation and, if untreated, tissue damage and death. Here, we describe a human case with a homozygous nonsense R688* RC3H1 mutation suffering from hyperinflammation, presenting as relapsing HLH. RC3H1 encodes Roquin-1, a posttranscriptional repressor of immuneregulatory proteins such as ICOS, OX40 and TNF. Comparing the R688* variant with the murine M199R variant reveals a phenotypic resemblance, both in immune cell activation, hypercytokinemia and disease development. Mechanistically, R688* Roquin-1 fails to localize to P-bodies and interact with the CCR4-NOT deadenylation complex, impeding mRNA decay and dysregulating cytokine production. The results from this unique case suggest that impaired Roquin-1 function provokes hyperinflammation by a failure to quench immune activation.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Helper T-cells; Macrophage Activation Syndrome; Constitutive-decay Element; Messenger-rna Decay; Hemophagocytic Lymphohistiocytosis; Roq Domain; Complex; Recognition; Disease; Regnase-1
Keywords plus
Language
Publication Year
2019
Prepublished in Year
HGF-reported in Year
2019
ISSN (print) / ISBN
2041-1723
e-ISSN
2041-1723
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 10,
Issue: 1,
Pages: ,
Article Number: 4779
Supplement: ,
Series
Publisher
Nature Publishing Group
Publishing Place
London
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Immune Response and Infection
PSP Element(s)
G-501712-001
Grants
Copyright
Erfassungsdatum
2019-10-24